Site updated at Wednesday, 22 June 2016

Living with Dementia

Transdermal Rivastigmine

Drug Patch Gets OK for Severe Alzheimer’s

The FDA has expanded the indication for transdermal rivastigmine to include patients with severe Alzheimer’s disease.

The approval means that the transdermal agent is indicated for use in any Alzheimer’s patient, irrespective of disease stage or severity. The expanded indication is the first of its type for any Alzheimer’s drug, according to a statement… Drug Patch Gets OK for Severe Alzheimer’s   

What is dementia?

greek paranoia1 - hd patients1 - risk for alzheimer's1 - low-density lipoprotein receptor-related protein 61 - sobrino1 - cognitive processes2 - amyloid β1 - antioxidants1 - lafora1 - behavioral symptoms1 - alzheimer disease6 - alzheimer type2 - forms of dementia2 - alzheimers and parkinsons1 - neurologic disorder1 - high-dose chemotherapy1 - diagnosing alzheimer's disease1 - tau tangles1 - pd dementia1 - dementia cases2 - apoe gene3 - dementia resistant1 - cases of parkinson's1 - intracoronary ultrasound1 - cancer1 - invisible disease1 - sign of alzheimer's1 - neurobiology1 - wernicke encephalopathy2 - memory lapses2 -